Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$42.98 - $49.77 $182,879 - $211,771
-4,255 Closed
0 $0
Q1 2022

Oct 26, 2022

BUY
$42.23 - $54.3 $179,688 - $231,046
4,255 New
4,255 $211,000
Q1 2022

May 06, 2022

BUY
$42.23 - $54.3 $179,688 - $231,046
4,255 New
4,255 $211,000
Q3 2020

Nov 02, 2020

SELL
$42.51 - $52.42 $23,295 - $28,726
-548 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$39.49 - $44.36 $21,640 - $24,309
548 New
548 $24,000
Q4 2019

Sep 02, 2020

SELL
$25.41 - $43.1 $4,472 - $7,585
-176 Closed
0 $0
Q3 2019

Nov 15, 2019

SELL
$32.73 - $40.81 $3,076 - $3,836
-94 Reduced 34.81%
176 $6,000
Q2 2019

Aug 14, 2019

BUY
$35.73 - $41.39 $3,358 - $3,890
94 Added 53.41%
270 $11,000
Q4 2018

Feb 13, 2019

BUY
$32.65 - $37.95 $5,746 - $6,679
176 New
176 $6,000

Others Institutions Holding QGEN

About QIAGEN N.V.


  • Ticker QGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 227,694,000
  • Market Cap $10.4B
  • Description
  • QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...
More about QGEN
Track This Portfolio

Track Balentine LLC Portfolio

Follow Balentine LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balentine LLC with notifications on news.